After three weeks of consistently taking C60 Power, I noticed a marked improvement in my energy. I’ve been taking C60 for about four months now and I feel GREAT.
C60 is a recently discovered, Nobel-Prize winning molecule, that looks similar to a cage-like soccer ball. C60 is found in nature and in the atmosphere of giant red stars. It is considered to be one of the most powerful antioxidants known.
C60 is characterized as a free-radical sponge and works at the cellular level by lifting the oxidative burden. C60 helps to optimize mitochondrial function by enhancing energy production in the cells. Most people note an increase in energy and mental clarity after consuming C60 on a daily basis for 30 days or more.
People use C60 to support their overall well-being in many ways. Many people are interested in C60’s ability to help optimize mitochondrial function, and its ability to promote a balanced immune response.
People who are noticing age-related memory loss appreciate C60, especially for its ability to promote energy and mental clarity. Many athletes note benefits to performance and decreased recovery times. C60 may promote skin vitality and hair growth and may lessen the appearance of fine lines and wrinkles when applied topically. People also use C60 for their pets to support longevity, a healthy immune response, and overall wellness.
THE MOST COMMON REASONS WHY PEOPLE CHOOSE TO CONSUME C60 INCLUDE:
- C60 optimizes mitochondrial function
- C60 promotes energy, mental clarity, and stamina
- C60 promotes a balanced immune response
- C60 supports athletic performance and recovery
- C60 may help with mild memory loss associated with aging
- C60 promotes skin vitality and hair growth
- C60 may lessen the appearance of fine lines and wrinkles when applied topically
C60 has been proven to be beneficial for both people and animals, including our beloved pets. There is a tremendous amount of information available about C60 and its benefits in everything from scientific research papers to real-person testimonials.
However, as a manufacturer, there are restrictions on what we can say on this website. If you would like more information about human studies completed on C60, please visit our research page.
FDA REGULATIONS REGARDING CARBON 60 | WHAT C60 COMPANIES CAN SAY
The US Food and Drug Administration currently prohibits all manufacturers of C60 products from making any claims about their ability to treat specific health conditions. Health claims are only permitted where approved by the FDA and based on accepted clinical trials.
C60 is not a drug and it is not intended to diagnose, treat, cure, mitigate, or prevent any disease.
Because C60 is relatively new to the market, the lengthy clinical trial period is still in process. We wish we could say more because we’re incredibly proud of what we do. We hear stories on a daily basis, from people all over the world, who have shared with us how C60 and C60 Power products have changed their lives.
As a company founded by a biogeochemist and research scientist, safety, purity, quality, and compliance with regard to manufacturing standards and agency regulations are a top priority for us. We’re confident our strict standard operating procedures and manufacturing processes will help to distinguish our high-quality products from lower-quality alternatives.
We encourage our customers to search online for additional C60 research available on the internet as well as personal testimonials of many thrilled customers.
Or join our loyal community of customers and give C60 Power a try today! Either way, we know you’ll be delighted by what you discover.
READY TO FEEL THE C60 POWER DIFFERENCE FOR YOURSELF?
References:
- Kroto, Harold W., et al. “C60: Buckminsterfullerene.” Nature, vol. 318, no. 6042, 1985, pp. 162–163. https://pubmed.ncbi.nlm.nih.gov/24409811/
- Andrievsky, Grigory V., et al. "Pharmacokinetics and Antioxidant Properties of C60 Fullerene in Rats." Fullerenes, Nanotubes and Carbon Nanostructures, vol. 16, no. 5-6, 2008, pp. 577-586. https://pubmed.ncbi.nlm.nih.gov/19755733/
- Quick, Kevin L., et al. "Carboxyfullerene SOD Mimetic Improves Cognition and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis." Neurobiology of Aging, vol. 33, no. 7, 2012, pp. 1418-1428. https://pubmed.ncbi.nlm.nih.gov/20036139/
- Chen, Liang-Ju, et al. “Fullerene Nanomaterials Inhibit the Allergic Response.” Journal of Immunology, vol. 179, no. 1, 2007, pp. 665–672. https://journals.aai.org/jimmunol/article/179/1/665/80873/Fullerene-Nanomaterials-Inhibit-the-Allergic
- Markovic, Zoran, et al. "C60 Fullerene in Orthopaedics: Cartilage and Bone Regeneration." Frontiers in Pharmacology, vol. 4, 2013, p. 175. https://pmc.ncbi.nlm.nih.gov/articles/PMC4124742/
- Chistyakov, V. A., et al. "Feasibility of the C60 Fullerene Antioxidant Study in a Model of Peritoneal Inflammation." Bulletin of Experimental Biology and Medicine, vol. 147, no. 6, 2009, pp. 726-729. https://www.semanticscholar.org/paper/Feasibility-of-the-C60-Fullerene-Antioxidant-Study-Chistyakov-Smirnova/627cd9f80521f8bdf8752e8ba7ce8952268053c2
- Dugan, Laura L., et al. "Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons." Neurobiology of Disease, vol. 3, no. 1, 1996, pp. 129-135. https://pubmed.ncbi.nlm.nih.gov/9173920/
- Tykhomyrov, Alexander A., et al. "Fullerene C60 Prevents Neurotoxicity Induced by Intrahippocampal Injection of Amyloid-β Peptide." Journal of Nanoscience and Nanotechnology, vol. 8, no. 10, 2008, pp. 5403-5412. https://pubmed.ncbi.nlm.nih.gov/19223242/
- Nakamura, Eiji, et al. “C60 Carboxyfullerene Exerts a Protective Activity Against Oxidative Stress-Induced Apoptosis in Human Peripheral Blood Mononuclear Cells.” Biochemical and Biophysical Research Communications, vol. 282, no. 3, 2001, pp. 704–709. C60_Carboxyfullerene_Exerts_a_Protective_Activity_against_Oxidative_Stress-Induced_Apoptosis_in_Human_Peripheral_Blood_Mononuclear_Cells
- Ali, Sameh S., et al. "A Biologically Effective Fullerene (C60) Derivative with Superoxide Dismutase Mimetic Properties." Free Radical Biology and Medicine, vol. 37, no. 8, 2004, pp. 1191-1202. https://pubmed.ncbi.nlm.nih.gov/15451059/
- Injac, Radmila, et al. "Protective Effects of Fullerenol C60(OH)24 against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats with Colorectal Carcinoma." Biomaterials, vol. 30, no. 6, 2009, pp. 1184-1196. https://pubmed.ncbi.nlm.nih.gov/19028561/